Trasis

About Trasis

Trasis is a Hot Cells & Shielding company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• STAT News · 2026-04-21
  Trasis partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Imaging Wire · 2026-03-26
  Trasis files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• PR Newswire · 2026-10-07
  Trasis publishes dosimetry data at SNMMI 2026
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Nuclear Medicine Today · 2026-05-24
  Trasis closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.